Encision Inc (ECIA) 0.3300 $ECIA Encision Reports First

New Post Public Reply Private Reply Replies (0) Message Board

Sep 20, 2016 at 1:11 AM

Encision Inc (ECIA) 0.3300 $ECIA

Encision Reports First Quarter Fiscal Year 2017 Results
PR Newswire - Tue Aug 02, 6:00AM CDT
Encision Inc. (ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2017 first quarter that ended June 30, 2016.

Encision Iterates AEM EndoShield® 2 Burn Protection System for Compatibility with New Generator Technology
PR Newswire - Fri Jun 03, 6:00AM CDT
Encision Inc. (ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced the enhancement of its recently released AEM EndoShield® 2 Burn Protection System ("EndoShield 2"

to interface with a market leading electrosurgical generator.

Encision Launches Its AEM EndoShield® 2 Burn Protection System
PR Newswire - Fri Apr 29, 6:00AM CDT
Encision Inc. (PK:ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield® 2 Burn Protection System ("EndoShield 2"

.

Encision Reports Third Quarter Fiscal Year 2016 Results
PR Newswire - Tue Feb 02, 6:00AM CST
Encision Inc. (PK:ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2016 third quarter that ended December 31, 2015.

Encision Reports Second Quarter Fiscal Year 2016 Results
PR Newswire - Wed Oct 28, 6:00AM CDT
Encision Inc. (PK:ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2016 second quarter that ended September 30, 2015.

Leading 200 Global Medical Devices/Technology/Supplies Companies that have Launched New Products
M2 - Thu Oct 22, 2:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qrcc44/global_new) has announced the addition of the "Global New Products Medical Devices/Technology/Supplies 200 " report to their offering. The newly launched report identifies 200 medical devices/technology/supplies companies globally that have launched New Products recently, and covers news of such 200 companies as well as provides details about new products launched by these companies. Medical scientists and physicians are constantly conducting research and testing new procedures to help prevent, diagnose, and cure diseases as well as developing new drugs and new medical products/devices/technology that can lessen symptoms or treat ailments. Profound insight into the companies' value drivers of innovation can release additional, untapped potential. From small innovations like adhesive bandages and ankle braces, to larger, more complex technologies like MRI machines, artificial organs, and robotic prosthetic limbs, technology has undoubtedly made an incredible impact on medicine. Highlights - Leading 200 global medical devices/technology/supplies companies that have launched new products recently covered - Provides detailed summary on new product categories - Summary of other news besides product launch for such companies - Important M&A and alliances of global medical devices/technology/supplies companies with new products - International presence of global medical devices/technology/supplies companies with new products Key Topics Covered: 1: Key New Products Launched by Global Medical Devices/Technology/Supplies Companies 2: Analysis of Global Medical Devices/Technology/Supplies Companies with New Products by Various Attributes 3: Key News of Global Medical Devices/Technology/Supplies Companies with New Products for Year 2014-15 4: Key Alliances of Global Medical Devices/Technology/Supplies Companies with New Products 5: International Presence of Global Medical Devices/Technology/Supplies Companies with New Products 6: Mergers and Acquisitions of Global Medical Devices/Technology/Supplies Companies with New Products Companies Mentioned - Partial List - 3D Systems Corporation - Accuray Inc - Acelity L.P. Inc - Affymetrix, Inc. - Aurora Spine Corp - Avita Medical Limited - AxoGen Inc. - Calgary Scientific Inc. - Cardica, Inc - Cardiocomm Solutions? - Carl Zeiss Meditec AG - Cellavision AB - CloudTag Inc - Cochlear Limited - Cogentix Medical Inc. - Coherent Incorporated - Electromed, Incorporation - Elekta publ AB - Encision Inc - Endologix, Inc. - Entellus Medical Inc - Exactech, Inc. - Exiqon AS - FEI Company - Fisher & Paykel Healthcare Corporation Limited - Fluidigm Corp. - Foundation Medicine Inc. - Fresenius Medical Care AG & Co. KGaA For more information visit http://www.researchandmarkets.com/research/qrcc44/global_new
AXGN: 8.51 (-0.06), DDD: 16.12 (+0.30), ARAY: 5.59 (+0.14), ELGX: 12.79 (-0.09), AFFX: 14.01 (+0.02), FEIC: 106.89 (+0.09), CGNT: 1.68 (-0.02), FMI: 23.76 (+1.01), FLDM: 8.13 (+0.05), ENTL: 19.24 (+0.15), CRDC: 2.35 (-0.15), EXAC: 27.68 (+0.13), COHR: 106.36 (+1.66)

Encision Reports Fourth Quarter And Fiscal Year 2015 Results
PR Newswire - Wed May 27, 6:00AM CDT
Encision Inc. (OTCQB:ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2015 fourth quarter and fiscal year ended March 31, 2015.

Encision to Present at LD Micro 7th Annual Main Event Conference
PR Newswire - Tue Nov 18, 6:00AM CST
Encision Inc. (OTCQB:ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it will present at the LD Micro 7th Annual Main Event Conference on Tuesday, December 2, at 5:30PM PST.

Encision Launches Its AEM EndoShield(TM) Burn Protection System
PR Newswire - Wed Nov 12, 6:00AM CST
Encision Inc. (OTCQB:ECIA), a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced that it has launched its AEM EndoShield(TM) Burn Protection System ("EndoShield"

.

Encision announces higher net loss of USD414,000 for Q2 fiscal 2015
M2 - Mon Nov 03, 6:08AM CST
Medical device company Encision (otherOTC:ECIA) stated on Friday its net loss of USD414,000 (USD0.04 per share) for its fiscal 2015 second quarter ended 30 September 2014.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

JOYEE N01 Debuts Globally with First 2,000 Deliveries

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

CVS Study: GLP-1 Drugs Effective But Costly

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...